2004
DOI: 10.1038/modpathol.3800156
|View full text |Cite
|
Sign up to set email alerts
|

Intravascular bone marrow accumulation in persistent polyclonal lymphocytosis: a misleading feature for B-cell neoplasm

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
25
1
4

Year Published

2006
2006
2021
2021

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 37 publications
(32 citation statements)
references
References 33 publications
2
25
1
4
Order By: Relevance
“…Thus, it is not apparent how improvements in CR rates with novel agents can therefore be considered 'cosmetic,' when they have led to significant prolongation in overall survival, as confirmed in multiple randomized trials. [3][4][5][6][7][8] Further, we do not agree that pursuing 'ever higher complete responses' by combining novel agents with conventional agents and/or transplant is unwarranted, especially as historical analyses of survival before and after the introduction of novel agents in clinical practice are showing a positive impact on patient survival, which is the first time in the last 20 years that such a change has been seen. 9,10 In the second part of the editorial, the commentary is much less clear.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Thus, it is not apparent how improvements in CR rates with novel agents can therefore be considered 'cosmetic,' when they have led to significant prolongation in overall survival, as confirmed in multiple randomized trials. [3][4][5][6][7][8] Further, we do not agree that pursuing 'ever higher complete responses' by combining novel agents with conventional agents and/or transplant is unwarranted, especially as historical analyses of survival before and after the introduction of novel agents in clinical practice are showing a positive impact on patient survival, which is the first time in the last 20 years that such a change has been seen. 9,10 In the second part of the editorial, the commentary is much less clear.…”
mentioning
confidence: 99%
“…Intravascular B-cell infiltrates, constantly associated with Bcl-2 immunostaining as seen in some lymphomas, have been reported in PPBL patients. 7 Moreover, multiple Bcl-2/IgH gene rearrangements, mostly polyclonal, but possibly leading to oligoclonal expansion, were observed contributing to the emergence of non-Hodgkin's lymphoma. The genetic predisposition, 8 the persistent viral infection, the chromosomal instability 9 or genetic alterations of ataxia-telangiectasiamutated and Rad3-related gene leading to loss of cell differentiation and cell-cycle abnormalities 10 could explain the possibility of increase of the risk of cancer.…”
mentioning
confidence: 99%
“…Nevertheless, some features could suggest a link between PPBL and SMZL. Both entities share same histologic patterns: 1/expansion of the white pulp of the spleen, with an enlargement of the marginal zone area of the follicles, and an intrasinusoidal infiltration of the red pulp [7,8] and 2/ intrasinusoidal infiltration by polyclonal B-cells in bone marrow [7,9]. Phenotypical characterization by MFC is also similar between the two entities, with the expression of surface IgM, CD19, CD20 and CD79b, but lacking the expression of CD5, CD10, CD23, CD43 and CD103 (WHO classification, 2008).…”
Section: Discussionmentioning
confidence: 99%
“…Bei der Mehrheit der Patienten finden sich polyklonale Rearrangements des IgH-Lokus mit dem BCL-2 Protoonkogen. Diese für das follikuläre Lymphom typische Translokation macht in der Differentialdiagnose die Abgrenzung zu einem leukämisch verlaufenden follikulären Lymphom notwendig [5]. Bei unserer Patientin konnten wir im peripheren Blut weder mittels FISH-Analyse noch mit PCR ein Rearrangement des IgH-Lokus nachweisen.…”
Section: äTiologie Und Pathogenese Der Ppblunclassified